Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas.

Galbraith K, Garcia M, Wei S, Chen A, Schroff C, Serrano J, Pacione D, Placantonakis DG, William CM, Faustin A, Zagzag D, Barbaro M, Eibl MDPGP, Shirahata M, Reuss D, Tran QT, Alom Z, von Deimling A, Orr BA, Sulman EP, Golfinos JG, Orringer DA, Jain R, Lieberman E, Feng Y, Snuderl M

Open source

DOI: 10.1093/neuonc/noae009
Published: 2024 Jun 3
Container: Neuro-oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/neuonc/noae009,
  title = {Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas.},
  author = {Galbraith K and Garcia M and Wei S and Chen A and Schroff C and Serrano J and Pacione D and Placantonakis DG and William CM and Faustin A and Zagzag D and Barbaro M and Eibl MDPGP and Shirahata M and Reuss D and Tran QT and Alom Z and von Deimling A and Orr BA and Sulman EP and Golfinos JG and Orringer DA and Jain R and Lieberman E and Feng Y and Snuderl M},
  year = {2024},
  journal = {Neuro-oncology},
  doi = {10.1093/neuonc/noae009},
  url = {https://doi.org/10.1093/neuonc/noae009}
}

RIS

TY  - JOUR
TI  - Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas.
AU  - Galbraith K
AU  - Garcia M
AU  - Wei S
AU  - Chen A
AU  - Schroff C
AU  - Serrano J
AU  - Pacione D
AU  - Placantonakis DG
AU  - William CM
AU  - Faustin A
AU  - Zagzag D
AU  - Barbaro M
AU  - Eibl MDPGP
AU  - Shirahata M
AU  - Reuss D
AU  - Tran QT
AU  - Alom Z
AU  - von Deimling A
AU  - Orr BA
AU  - Sulman EP
AU  - Golfinos JG
AU  - Orringer DA
AU  - Jain R
AU  - Lieberman E
AU  - Feng Y
AU  - Snuderl M
PY  - 2024
JO  - Neuro-oncology
DO  - 10.1093/neuonc/noae009
UR  - https://doi.org/10.1093/neuonc/noae009
ER  -

APA

K, G., M, G., S, W., A, C., C, S., J, S., D, P., DG, P., CM, W., A, F., D, Z., M, B., MDPGP, E., M, S., D, R., QT, T., Z, A., A, V. D., BA, O., EP, S., JG, G., DA, O., R, J., E, L., Y, F., & M, S. (2024). Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas.. Neuro-oncology. https://doi.org/10.1093/neuonc/noae009

Source records

pubmed · retrieved 2026-09-25T01:59:33.139Z